UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 465

Sortiert nach

Electrode materials used for electrochemical oxidation of organic compounds in wastewater

Reviews in environmental science and biotechnology, 2017-06, Vol.16 (2), p.223-238

2017

Volltextzugriff (PDF)

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

Cardiovascular diabetology, 2018-11, Vol.17 (1), p.150-150, Article 150

2018

Volltextzugriff (PDF)

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.427-437

2018

Volltextzugriff (PDF)

Removal of dichloromethane from ground and wastewater: A review

Chemosphere (Oxford), 2013-10, Vol.93 (7), p.1258-1267

2013

Volltextzugriff (PDF)

Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study

Diabetes research and clinical practice, 2019-05, Vol.151, p.20-32

2019

Volltextzugriff (PDF)

Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study

The American heart journal, 2022-01, Vol.243, p.232-239

2022

Volltextzugriff (PDF)

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

Diabetologia, 2020-04, Vol.63 (4), p.711-721

2020

Volltextzugriff (PDF)

1002-P: HbA1c Level in Severe COVID-19 Patients Is Not Only a Marker of Glycemic Status but Also of Acute Erythrocyte Damage

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Diagnosing impaired glucose tolerance using direct infusion mass spectrometry of blood plasma

PloS one, 2014-09, Vol.9 (9), p.e105343-e105343

2014

Volltextzugriff (PDF)

Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme

Diabetes, obesity & metabolism, 2020-01, Vol.22 (1), p.66-78

2020

Volltextzugriff (PDF)

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study

Diabetes, obesity & metabolism, 2023-01, Vol.25 (1), p.46-55

2023

Volltextzugriff (PDF)

Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital

PloS one, 2022-11, Vol.17 (11), p.e0275381-e0275381

2022

Volltextzugriff (PDF)

DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS

Sakharnyĭ diabet, 2020-02, Vol.22 (6), p.592-601

Shestakova, Marina V.

2020

Volltextzugriff (PDF)

What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study

Diabetes, obesity & metabolism, 2021-10, Vol.23 (10), p.2336-2343

2021

Volltextzugriff (PDF)

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Scientific reports, 2022-03, Vol.12 (1), p.3474-3474, Article 3474

2022

Volltextzugriff (PDF)

Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study

Diabetes research and clinical practice, 2022-03, Vol.185, p.109218-109218, Article 109218

2022

Volltextzugriff (PDF)

Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study

Diabetes research and clinical practice, 2021-08, Vol.178, p.108947-108947, Article 108947

2021

Volltextzugriff (PDF)

Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study

Diabetes, obesity & metabolism, 2021-08, Vol.23 (8), p.1956-1960

2021

Volltextzugriff (PDF)

Regulation of Adipose Tissue Stem Cells Angiogenic Potential by Tumor Necrosis Factor-Alpha

Journal of cellular biochemistry, 2016-01, Vol.117 (1), p.180-196

2016

Volltextzugriff (PDF)

Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study

Diabetes, obesity & metabolism, 2022-09, Vol.24 (9), p.1734-1740

2022

Volltextzugriff (PDF)

1703-P: Altered UCP1 Expression in ADSC-Derived Beige Adipocytes Determines Mitochondrial ROS Production in T2DM Patients

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry

Sakharnyĭ diabet, 2017-05, Vol.20 (1), p.13-41

2017

Volltextzugriff (PDF)

AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess

International journal of molecular sciences, 2021-12, Vol.23 (1), p.211

2021

Volltextzugriff (PDF)

Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study

Diabetes research and clinical practice, 2021-10, Vol.180, p.108974-108974, Article 108974

2021

Volltextzugriff (PDF)

Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus

Metabolites, 2024-03, Vol.14 (3), p.168

2024

Volltextzugriff (PDF)

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(428)
Mit Volltextzugriff
(440)

Publikationsform

Sprache

Englisch
(457)
Russisch
(138)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(253)
Life Sciences & Biomedicine
(232)
Endocrinology & Metabolism
(193)
Diabetes Mellitus
(132)
Humans
(64)
Diabetes
(56)
Type 2 Diabetes
(50)
Type 2 Diabetes Mellitus
(39)
Middle Aged
(36)
Male
(35)
Сахарный Диабет
(35)
Female
(34)
Diabetes Mellitus, Type 2 - Drug Therapy
(30)
Insulin
(30)
Glucose
(28)
Patients
(27)
Obesity
(26)
Adult
(25)
Insulin Resistance
(25)
Aged
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Electrode materials used for electrochemical oxidation of organic compounds in wastewater

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

Removal of dichloromethane from ground and wastewater: A review

Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study

Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

1002-P: HbA1c Level in Severe COVID-19 Patients Is Not Only a Marker of Glycemic Status but Also of Acute Erythrocyte Damage

Diagnosing impaired glucose tolerance using direct infusion mass spectrometry of blood plasma

Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study

Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital

DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS

What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study

Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study

Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study

Regulation of Adipose Tissue Stem Cells Angiogenic Potential by Tumor Necrosis Factor-Alpha

Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study

1703-P: Altered UCP1 Expression in ADSC-Derived Beige Adipocytes Determines Mitochondrial ROS Production in T2DM Patients

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry

AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess

Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study

Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus

Suchergebnisse filtern